Literature DB >> 25755422

Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.

Alita Mishra1, Zobair M Younossi2.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is an important cause of liver disease burden across the world. By definition, although the histopathologic features of NAFLD are identical to that of alcoholic liver disease, its diagnosis requires absence of significant alcohol use and absence of other causes of chronic liver disease. We now know that NAFLD is not simply a disease of the Western world. It is manifested across the world, in varying rates, across gender, across varying ethnicities, and in its association with other host factors. In this review article, the definition of NAFLD, its spectrum, ranging from mild steatosis to hepatocellular injury and inflammation defined as non-alcoholic steatohepatitis (NASH) is discussed. Mild steatosis is generally a stable disease whereas NASH can be progressive. Based on current published literature, current incidence and prevalence of NAFLD and NASH are discussed. It is also accepted that these processes will continue to increase in prevalence with the rise of obesity, type II diabetes, and associated metabolic syndrome. Some of the risk factors have been well-established and are discussed. In addition, this review also presents emerging associations with other risk factors for NAFLD. Natural history of NAFLD is variable depending upon the histologic subtypes and other underlying comorbidities and is discussed in this review as well.

Entities:  

Keywords:  CVD, cardiovascular disease; HCC, hepatocellular carcinoma; NAFLD; NAFLD, non-alcoholic fatty liver disease; NASH; NASH, non-alcoholic steatohepatitis; NHANES, National Health and Nutrition Examination Surveys; OSA, obstructive sleep apnea; PCOS, polycystic ovarian syndrome

Year:  2012        PMID: 25755422      PMCID: PMC3940561          DOI: 10.1016/S0973-6883(12)60102-9

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  89 in total

1.  Influence of ethnicity on histological differences in non-alcoholic fatty liver disease.

Authors:  Smruti R Mohanty; Tara N Troy; Dezheng Huo; Bridget L O'Brien; Donald M Jensen; John Hart
Journal:  J Hepatol       Date:  2009-01-01       Impact factor: 25.083

2.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

3.  Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.

Authors:  Camilo Boza; Arnoldo Riquelme; Luis Ibañez; Ignacio Duarte; Enrique Norero; Paola Viviani; Alejandro Soza; Jose Ignacio Fernandez; Alejandro Raddatz; Sergio Guzman; Marco Arrese
Journal:  Obes Surg       Date:  2005-09       Impact factor: 4.129

4.  Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.

Authors:  Nadya Kagansky; Shmuel Levy; Daniel Keter; Ephraim Rimon; Zhomicky Taiba; Zvi Fridman; David Berger; Hilla Knobler; Stephen Malnick
Journal:  Liver Int       Date:  2004-12       Impact factor: 5.828

5.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

6.  Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.

Authors:  Maria Stepanova; Nila Rafiq; Zobair M Younossi
Journal:  Gut       Date:  2010-07-26       Impact factor: 23.059

7.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Authors:  Masahide Hamaguchi; Takao Kojima; Noriyuki Takeda; Chisato Nagata; Jun Takeda; Hiroshi Sarui; Yutaka Kawahito; Naohisa Yoshida; Atsushi Suetsugu; Takahiro Kato; Junichi Okuda; Kazunori Ida; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

8.  Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup.

Authors:  Tamaki Yamada; Mitsuru Fukatsu; Sadao Suzuki; Tsuneya Wada; Takashi Yoshida; Takashi Joh
Journal:  J Gastroenterol Hepatol       Date:  2009-10-09       Impact factor: 4.029

9.  Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery.

Authors:  Florence Harnois; Simon Msika; Jean-Marc Sabaté; Charlotte Mechler; Pauline Jouet; Jeanine Barge; Benoit Coffin
Journal:  Obes Surg       Date:  2006-02       Impact factor: 4.129

10.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

View more
  30 in total

Review 1.  Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis.

Authors:  A L L Rocha; L C Faria; T C M Guimarães; G V Moreira; A L Cândido; C A Couto; F M Reis
Journal:  J Endocrinol Invest       Date:  2017-06-13       Impact factor: 4.256

2.  Metabolic Syndrome Is Associated with Health-Related Quality of Life in Suspected Patients with Nonalcoholic Steatohepatitis.

Authors:  Ali Gholami; Farhad Zamani; Bayan Hosseini; Rahim Sharafkhani; Mansooreh Maadi; Zahra Moosavi Jahromi; Maryam Khazaee-Pool; Masoudreza Sohrabi
Journal:  Med Princ Pract       Date:  2018-02-05       Impact factor: 1.927

3.  Identifying patients at risk from nonalcoholic fatty liver-related hepatocellular carcinomas.

Authors:  Mehmet Sayiner; Zobair M Younossi
Journal:  Hepat Oncol       Date:  2016-03-23

4.  Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis.

Authors:  Xiaoyan Zhang; Sha Li; Yunfeng Zhou; Wen Su; Xiongzhong Ruan; Bing Wang; Feng Zheng; Margaret Warner; Jan-Åke Gustafsson; Youfei Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-07       Impact factor: 11.205

Review 5.  Updates on Molecular Targets and Epigenetic-Based Therapies for PCOS.

Authors:  Viktor V Smirnov; Narasimha M Beeraka; Dmitry Yu Butko; Vladimir N Nikolenko; Sergey A Bondarev; Evgeniy E Achkasov; Mikhail Y Sinelnikov; P R Hemanth Vikram
Journal:  Reprod Sci       Date:  2022-06-28       Impact factor: 2.924

Review 6.  Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.

Authors:  Pegah Golabi; Cameron T Locklear; Patrick Austin; Sophie Afdhal; Melinda Byrns; Lynn Gerber; Zobair M Younossi
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

7.  Relevance of low testosterone to non-alcoholic fatty liver disease.

Authors:  Avni Mody; Donna White; Fasiha Kanwal; Jose M Garcia
Journal:  Cardiovasc Endocrinol       Date:  2015-09-01

Review 8.  Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase.

Authors:  Niharika Samala; Sarah A Tersey; Naga Chalasani; Ryan M Anderson; Raghavendra G Mirmira
Journal:  J Diabetes Complications       Date:  2017-07-31       Impact factor: 2.852

9.  Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study.

Authors:  Maggie A Stanislawski; Jessica Shaw; Elizabeth Litkowski; Ethan M Lange; Wei Perng; Dana Dabelea; Leslie A Lange
Journal:  J Pediatr       Date:  2020-03-04       Impact factor: 4.406

Review 10.  Interaction of volatile organic compounds and underlying liver disease: a new paradigm for risk.

Authors:  Anna L Lang; Juliane I Beier
Journal:  Biol Chem       Date:  2018-10-25       Impact factor: 4.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.